This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Benlot, C. Articles by Joubert, D. Search for Related Content PubMed PubMed Citation Articles by Benlot, C. Articles by Joubert, D. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Breast Cancer

Somatostatin and Growth Hormone-Releasing Hormone in Normal and Tumoral Human Breast Tissue: Endogenous Content, in Vitro Pulsatile Release, and Regulation

Service de Biochimie Médicale (C.B.), Paris; INSERM U-401 (L.L., D.J.) and UPR 9055 (P.F.), Montpellier; Laboratoires Sandoz (A.R.), Rueil-Malmaison; and Centre Val d’Aurelle (P.R.), Montpellier, France

Address all correspondence and requests for reprints to: Dr. Dominique Joubert, INSERM U-401, 141 rue de la Cardonille, 34094 Montpellier Cedex 05, France.

Endogenous production of SRIH and GHRH was analyzed in human breast tissue. SRIH precursor (pro-SRIH) was identified after Sephadex G-50 filtration of acetic acid extracts of normal and tumoral human breast samples. SRIH-(1–14) or -(1–28) could not be detected in breast tissue, whereas the immunoreactive SRIH released in vitro was characterized as SRIH-(1–28). Endogenous production of GHRH was assessed by identification of GHRH messenger ribonucleic acid by PCR followed by sequencing of the amplified complementary DNA and by high performance liquid chromatographic characterization of immunoreactive GHRH contained in the tissue and released in vitro. There were no differences in pro-SRIH or GHRH-(1–44) tissue contents between normal and tumoral samples. The release of both peptides was evidenced in perifusion and static incubation. Perifusion of normal breast tissue (n = 3) showed pulsatile release of SRIH and GHRH. Perifusion of tumors (n = 4) showed SRIH release in 50% of the cases. SRIH release was pulsatile in one case. GHRH release was observed in the four tumoral samples analyzed, but was pulsatile in only one case. In static incubation, tumors (n = 6) secreted 13 times more GHRH than did normal samples (n = 3; 383 ± 92 vs. 29.6 ± 4.6 fmol/mg protein; P < 0.05). Stimulation of GHRH release by exogenous SRIH was observed only with the normal tissue.

Together these data provide evidence for the existence of local production of SRIH and GHRH by human breast. Hypersecretion of GHRH by breast tumors indicates that this peptide could play a role in maintaining epithelial cell proliferation as is the case for other peptides produced locally.

This article has been cited by other articles:

				G. Siriwardana, A. Bradford, D. Coy, and P. Zeitler Autocrine/Paracrine Regulation of Breast Cancer Cell Proliferation by Growth Hormone Releasing Hormone via Ras, Raf, and Mitogen-Activated Protein Kinase Mol. Endocrinol., September 1, 2006; 20(9): 2010 - 2019. [Abstract] [Full Text] [PDF]

				K. Wagner, K. Hemminki, E. Grzybowska, R. Klaes, B. Burwinkel, P. Bugert, R. K. Schmutzler, B. Wappenschmidt, D. Butkiewicz, J. Pamula, et al. Polymorphisms in genes involved in GH1 release and their association with breast cancer risk Carcinogenesis, September 1, 2006; 27(9): 1867 - 1875. [Abstract] [Full Text] [PDF]

				G. Keller, A. V. Schally, K. Groot, G. L. Toller, A. Havt, F. Koster, P. Armatis, G. Halmos, M. Zarandi, J. L. Varga, et al. Effective treatment of experimental human non-Hodgkin's lymphomas with antagonists of growth hormone-releasing hormone PNAS, July 26, 2005; 102(30): 10628 - 10633. [Abstract] [Full Text] [PDF]

				J. B. Engel, G. Keller, A. V. Schally, G. L. Toller, K. Groot, A. Havt, P. Armatis, M. Zarandi, J. L. Varga, and G. Halmos Inhibition of Growth of Experimental Human Endometrial Cancer by an Antagonist of Growth Hormone-Releasing Hormone J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3614 - 3621. [Abstract] [Full Text] [PDF]

				Z. Szereday, A. V. Schally, J. L. Varga, C. A. Kanashiro, F. Hebert, P. Armatis, K. Groot, K. Szepeshazi, G. Halmos, and R. Busto Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma Cancer Res., November 15, 2003; 63(22): 7913 - 7919. [Abstract] [Full Text] [PDF]

				R. Busto, A. V. Schally, J. L. Varga, M. O. Garcia-Fernandez, K. Groot, P. Armatis, and K. Szepeshazi The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas PNAS, September 3, 2002; 99(18): 11866 - 11871. [Abstract] [Full Text] [PDF]

				O. Khorram, M. Garthwaite, and T. Golos The Influence of Aging and Sex Hormones on Expression of Growth Hormone-Releasing Hormone in the Human Immune System J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3157 - 3161. [Abstract] [Full Text] [PDF]

				V. J. Csernus, A. V. Schally, H. Kiaris, and P. Armatis Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro PNAS, March 16, 1999; 96(6): 3098 - 3103. [Abstract] [Full Text] [PDF]

				Z. Kahán, J. M. Arencibia, V. J. Csernus, K. Groot, R. D. Kineman, W. R. Robinson, and A. V. Schally Expression of Growth Hormone-Releasing Hormone (GHRH) Messenger Ribonucleic Acid and the Presence of Biologically Active GHRH in Human Breast, Endometrial, and Ovarian Cancers J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 582 - 589. [Abstract] [Full Text]

				H. Kiaris and A. V. Schally Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone PNAS, January 5, 1999; 96(1): 226 - 231. [Abstract] [Full Text] [PDF]

				Z. Rekasi, T. Czompoly, A. V. Schally, and G. Halmos Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers PNAS, September 12, 2000; 97(19): 10561 - 10566. [Abstract] [Full Text] [PDF]